Update on the Status of Medication Abortion and the Courts April 21, 2023 Blog This policy watch explains the April 21, 2023 United States Supreme Court’s ruling on Alliance for Hippocratic Medicine v. FDA, a case challening the FDA’s approval of mifepristone, the medication abortion pill.
Disparities in Health and Health Care: 5 Key Questions and Answers April 21, 2023 Issue Brief Disparities in health and health care for people of color and underserved groups are longstanding challenges. This brief provides an introduction to what health and health care disparities are, why it is important to address disparities, the status of disparities today, recent federal actions to address disparities, and key issues related to addressing disparities looking ahead.
Q & A: Implications of Two Conflicting Federal Court Rulings on the Availability of Medication Abortion and the FDA’s Authority to Regulate Drugs April 8, 2023 Blog This policy watch explains the two conflicting rulings on the provision of mifepristone issued by two separate District Courts on April 7, 2023, Alliance for Hippocratic Medicine v. FDA and State of Washington v. United States Food and Drug Administration.
Parental Consent/Notification Requirements for Minors Seeking Abortions April 6, 2023 State Indicator
After Dobbs, Survey Seeks to Understand Telecontraception Clients Better April 4, 2023 News Release According to a new KFF survey with a nonprobability sample of clients from four online sources of contraception, one in four clients said they got emergency contraception to have on hand because of the Supreme Court’s decision to overturn Roe v. Wade. Additionally, more than a fifth (22%) said they…
Who Uses Telecontraception and Why? A Closer Look at Clients of Four Telecontraception Companies April 4, 2023 Issue Brief Based on the findings of a nonprobability sample of 6,000 survey respondents from four telecontraception companies, this brief presents a snapshot of telecontraception users and their reasons for using these platforms.
As the Courts Weigh the Future of the ACA’s Preventive Services Coverage, a New Analysis Shows that Most People with Private Insurance Received At Least One of Those Benefits in 2018 March 20, 2023 News Release The provision of the Affordable Care Act (ACA) that requires most private health plans to cover many preventive services without any cost-sharing for their enrollees is being challenged in federal court. The U.S. District Court in the Northern District of Texas in September concluded that aspects of the requirement were…
Challenges to the FDA’s Approval of Medication Abortion Pills Could Curtail Access Throughout the United States March 14, 2023 News Release In anticipation of a ruling in a case with enormous implications for access to medication abortion in the United States, a new KFF brief explains the impact of this case, and others filed in federal courts, involving the FDA’s regulation of medication abortion. The case that has gotten the most…
Legal Challenges to the FDA Approval of Medication Abortion Pills March 13, 2023 Issue Brief This issue brief details the Alliance of Hippocratic Medicine challenge to the FDA’s approval of the abortion pill, mifepristone. It provides context for the challenge, as well as what some of the possible rulings in the case could mean for access to medication abortion.
Medication Abortion in the Courts: What’s at Stake? March 8, 2023 News Release Access to medication abortion has emerged as a central issue following the Dobbs decision overturning Roe v. Wade. There is ongoing litigation in four federal cases about the FDA’s approval and regulation of mifepristone, one of the two drugs used in medication abortion. Mifepristone, approved by the FDA in 2000,…